Carol R Reed

Summary

Affiliation: Yale University
Country: USA

Publications

  1. ncbi The efficacy profile of vilazodone, a novel antidepressant for the treatment of major depressive disorder
    Carol R Reed
    Dogwood Pharmaceuticals, New Haven, CT 06511, USA
    Curr Med Res Opin 28:27-39. 2012
  2. ncbi Candidate gene analysis identifies a polymorphism in HLA-DQB1 associated with clozapine-induced agranulocytosis
    Maria C Athanasiou
    PGxHealth, 5 Science Park, New Haven, CT 06511, USA
    J Clin Psychiatry 72:458-63. 2011

Detail Information

Publications2

  1. ncbi The efficacy profile of vilazodone, a novel antidepressant for the treatment of major depressive disorder
    Carol R Reed
    Dogwood Pharmaceuticals, New Haven, CT 06511, USA
    Curr Med Res Opin 28:27-39. 2012
    ..The objective is to summarize the efficacy profile of vilazodone at its approved dose of 40 mg/day...
  2. ncbi Candidate gene analysis identifies a polymorphism in HLA-DQB1 associated with clozapine-induced agranulocytosis
    Maria C Athanasiou
    PGxHealth, 5 Science Park, New Haven, CT 06511, USA
    J Clin Psychiatry 72:458-63. 2011
    ..This analysis of 74 candidate genes was designed to identify an association between sequence variants and clozapine-induced agranulocytosis (CIA)...